Recent advances in adjuvant therapy for breast cancer

Frances M. Palmieri, Edith A. Perez

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


OBJECTIVES: To review recent studies that may influence the adjuvant treatment of patients with breast cancer. Studies reviewed evaluate the role of aromatase inhibitors, incorporation of taxanes into chemotherapy regimens, novel dosage schedules, and supportive care with epoetin alfa. DATA SOURCES: Published literature and clinical experience. CONCLUSION: Recent evidence suggests that aromatase inhibitors are more effective than tamoxifen as hormonal adjuvant therapy and that the addition of taxanes to adjuvant chemotherapy improves outcome. Supportive care is also an important component of therapy. IMPLICATIONS FOR NURSING PRACTICE: Knowledge of recent advances in adjuvant therapy for breast cancer will contribute to greater efficacy in patient care.

Original languageEnglish (US)
Pages (from-to)10-16
Number of pages7
JournalSeminars in Oncology Nursing
Issue numberSUPPL. 2
StatePublished - 2003

ASJC Scopus subject areas

  • Oncology(nursing)


Dive into the research topics of 'Recent advances in adjuvant therapy for breast cancer'. Together they form a unique fingerprint.

Cite this